pyrroles has been researched along with Carditis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aramburu, O; Arévalo, M; Arias, JL; Blanca, AJ; Mate, A; Miguel-Carrasco, JL; Ruiz-Armenta, MV; Vázquez, CM; Zambrano, S | 1 |
| Wu, S; Zhang, A; Zhang, H | 1 |
| Dong, W; Guan, J; Liang, Y; Sun, X; Wang, G; Zhang, L; Zhu, J | 1 |
| Gao, C; Li, WM; Liu, W; Sun, NL | 1 |
| Gao, C; Li, WM; Liu, W; Zhou, BG | 1 |
| Chen, L; Huang, J; Qian, H; Shen, D; Tang, Q; Wang, H; Wang, T; Wu, H; Xiong, R | 1 |
| Cheah, AY; Dawood, F; Lee, JK; Liu, P; Rabinovitch, M; Saiki, Y; Wen, WH; Zaidi, SH | 1 |
7 other study(ies) available for pyrroles and Carditis
| Article | Year |
|---|---|
Inflammatory and fibrotic processes are involved in the cardiotoxic effect of sunitinib: Protective role of L-carnitine.
Topics: Animals; Antineoplastic Agents; Blood Pressure; Cardiotonic Agents; Cardiotoxicity; Carnitine; Cytokines; Endomyocardial Fibrosis; Gene Expression; Heart Diseases; Indoles; Male; Myocarditis; Myocytes, Cardiac; NF-kappa B; Pyrroles; Rats; Rats, Wistar; RNA, Messenger; Sunitinib | 2016 |
Immunomodulation by atorvastatin upregulates expression of gap junction proteins in coxsackievirus B3 (CVB3)-induced myocarditis.
Topics: Animals; Atorvastatin; Blotting, Western; Connexin 43; Connexins; Coxsackievirus Infections; Cytokines; Enzyme-Linked Immunosorbent Assay; Heptanoic Acids; Immunohistochemistry; Immunologic Factors; Interferon-gamma; Mice; Myocarditis; Pyrroles; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha; Up-Regulation | 2010 |
Atorvastatin attenuates Coxsackie virus B3m-induced viral myocarditis in mice.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Atorvastatin; Coxsackievirus Infections; Fas Ligand Protein; fas Receptor; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Myocarditis; Myocardium; Pyrroles; RNA, Messenger; Troponin I | 2010 |
Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats.
Topics: Animals; Atorvastatin; Autoimmune Diseases; Cholesterol; Cytokines; Genetic Predisposition to Disease; Heart Function Tests; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocarditis; Myocardium; Pyrroles; Rats; Rats, Inbred Lew; Th1 Cells; Th2 Cells | 2005 |
Immunoregulatory effects of atorvastatin on experimental autoimmune myocarditis in Lewis rats.
Topics: Adoptive Transfer; Animals; Atorvastatin; Autoimmune Diseases; Disease Models, Animal; Echocardiography; Enzyme-Linked Immunosorbent Assay; Genes, MHC Class II; Heptanoic Acids; Histocompatibility Antigens Class II; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocarditis; Myocardium; Myocytes, Cardiac; Nuclear Proteins; Polymerase Chain Reaction; Pyrroles; Rats; Rats, Inbred Lew; RNA, Messenger; T-Lymphocytes; Th2 Cells; Trans-Activators | 2006 |
Antiarrhythmic effect of atorvastatin on autoimmune myocarditis is mediated by improving myocardial repolarization.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Atorvastatin; Autoimmune Diseases; Disease Models, Animal; Heart; Heart Ventricles; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interferon-gamma; Mice; Mice, Inbred BALB C; Myocarditis; Myocardium; Myocytes, Cardiac; Patch-Clamp Techniques; Potassium Channels; Pyrroles; Tumor Necrosis Factor-alpha; Ventricular Function | 2007 |
A serine elastase inhibitor reduces inflammation and fibrosis and preserves cardiac function after experimentally-induced murine myocarditis.
Topics: Administration, Oral; Animals; Cardiovirus Infections; Disease Models, Animal; Encephalomyocarditis virus; Fibrosis; Heart; Inflammation; Male; Mice; Mice, Inbred DBA; Microcirculation; Myocarditis; Myocardium; Perfusion; Peroxidase; Pyrroles; Serine Proteinase Inhibitors; Sulfonamides | 1998 |